These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16740099

  • 21. In vitro antibacterial activity of the manuka essential oil from Leptospermum scoparium combined with Tris-EDTA against Gram-negative bacterial isolates from dogs with otitis externa.
    Song SY, Hyun JE, Kang JH, Hwang CY.
    Vet Dermatol; 2020 Apr; 31(2):81-85. PubMed ID: 31729809
    [Abstract] [Full Text] [Related]

  • 22. In vitro antimicrobial activity of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA.
    Guardabassi L, Ghibaudo G, Damborg P.
    Vet Dermatol; 2010 Jun; 21(3):282-6. PubMed ID: 20030799
    [Abstract] [Full Text] [Related]

  • 23. Corynebacterium spp. in dogs and cats with otitis externa and/or media: a retrospective study.
    Henneveld K, Rosychuk RA, Olea-Popelka FJ, Hyatt DR, Zabel S.
    J Am Anim Hosp Assoc; 2012 Jun; 48(5):320-6. PubMed ID: 22843832
    [Abstract] [Full Text] [Related]

  • 24. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs.
    Zamankhan Malayeri H, Jamshidi S, Zahraei Salehi T.
    Vet Res Commun; 2010 Jun; 34(5):435-44. PubMed ID: 20526674
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of an ear cleanser for the treatment of infectious otitis externa in dogs.
    Cole LK, Kwochka KW, Kowalski JJ, Hillier A, Hoshaw-Woodard SL.
    Vet Ther; 2003 Jun; 4(1):12-23. PubMed ID: 12756632
    [Abstract] [Full Text] [Related]

  • 26. Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants.
    Chan WY, Hickey EE, Page SW, Trott DJ, Hill PB.
    J Vet Pharmacol Ther; 2019 Nov; 42(6):682-692. PubMed ID: 31503362
    [Abstract] [Full Text] [Related]

  • 27. Comparison of microbial isolates and susceptibility patterns from the external ear canal of dogs with otitis externa.
    Graham-Mize CA, Rosser EJ.
    J Am Anim Hosp Assoc; 2004 Nov; 40(2):102-8. PubMed ID: 15007044
    [Abstract] [Full Text] [Related]

  • 28. Bacterial contamination of commercial ear cleaners following routine home use.
    Bartlett SJ, Rosenkrantz WS, Sanchez S.
    Vet Dermatol; 2011 Dec; 22(6):546-53. PubMed ID: 21645141
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of in vitro activity of two topical products against three organisms isolated from canine referral patients with otitis externa and cutaneous pyoderma.
    Okwumabua O, Goodman F, Elfassy O.
    Vet Ther; 2000 Dec; 1(4):261-3. PubMed ID: 19757573
    [Abstract] [Full Text] [Related]

  • 30. Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia.
    Bugden DL.
    Aust Vet J; 2013 Dec; 91(1-2):43-6. PubMed ID: 23356371
    [Abstract] [Full Text] [Related]

  • 31. In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa.
    Chan WY, Hickey EE, Khazandi M, Page SW, Trott DJ, Hill PB.
    Vet Dermatol; 2018 Apr; 29(2):149-e57. PubMed ID: 29363210
    [Abstract] [Full Text] [Related]

  • 32. Variability of laboratory identification and antibiotic susceptibility reporting of Pseudomonas spp. isolates from dogs with chronic otitis externa.
    Schick AE, Angus JC, Coyner KS.
    Vet Dermatol; 2007 Apr; 18(2):120-6. PubMed ID: 17355427
    [Abstract] [Full Text] [Related]

  • 33. Comparison of bacterial organisms and their susceptibility patterns from otic exudate and ear tissue from the vertical ear canal of dogs undergoing a total ear canal ablation.
    Cole LK, Kwochka KW, Hillier A, Kowalski JJ, Smeak DD.
    Vet Ther; 2005 Apr; 6(3):252-9. PubMed ID: 16299671
    [Abstract] [Full Text] [Related]

  • 34. In vitro effect of combinations of antimicrobial agents and EDTA-tromethamine on certain gram-positive bacteria.
    Wooley RE, Jones MS, Gilbert JP, Shotts EB.
    Am J Vet Res; 1983 Nov; 44(11):2167-9. PubMed ID: 6418038
    [Abstract] [Full Text] [Related]

  • 35. Effect of chlorhexidine/EDTA/Tris against bacterial isolates from clinical specimens.
    Harper WE, Epis JA.
    Microbios; 1987 Nov; 51(207):107-12. PubMed ID: 3116368
    [Abstract] [Full Text] [Related]

  • 36. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
    Ganière JP, Médaille C, Etoré F.
    Res Vet Sci; 2004 Aug; 77(1):67-71. PubMed ID: 15120955
    [Abstract] [Full Text] [Related]

  • 37. Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
    Cole LK, Kwochka KW, Hillier A, Kowalski JJ, Smeak DD, Kelbick NT.
    Vet Dermatol; 2006 Apr; 17(2):128-33. PubMed ID: 16515655
    [Abstract] [Full Text] [Related]

  • 38. Antibacterial effect of N-acetylcysteine on common canine otitis externa isolates.
    May ER, Conklin KA, Bemis DA.
    Vet Dermatol; 2016 Jun; 27(3):188-e47. PubMed ID: 27122224
    [Abstract] [Full Text] [Related]

  • 39. Coryneform bacteria associated with canine otitis externa.
    Aalbæk B, Bemis DA, Schjærff M, Kania SA, Frank LA, Guardabassi L.
    Vet Microbiol; 2010 Oct 26; 145(3-4):292-8. PubMed ID: 20434850
    [Abstract] [Full Text] [Related]

  • 40. Otitis externa in the dog -- a clinical and microbiological study.
    Krogh HV, Linnet A, Knudsen PB.
    Nord Vet Med; 1975 May 26; 27(5):285-95. PubMed ID: 807907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.